Johnson & Johnson / Eli Lilly and Company / AstraZeneca Pharmaceuticals LP / Bristol-Myers Squibb Company / Novartis Pharmaceuticals Corporation / C-Path / US Inc. / GlaxoSmithKline / Pfizer Inc. / F. Hoffmann-La Roche Ltd / Genentech Inc. / CHDI Foundation Inc / / /
Facility
Forest Research Institute / Critical Path Institute / National Institute of Aging / About Critical Path Institute / /
IndustryTerm
Alzheimer’s disease therapies / pharmaceutical / therapies for major diseases / biopharmaceutical / /
Brookings Institution / Alzheimer’s Association / Forest Research Institute / Committee on Energy and Commerce / CAMD’s mission / Critical Path Institute / National Institute of Aging / National Health Council / Michael J. Fox Foundation / Parkinson's Disease Foundation / Alzheimer’s Foundation of America / EXECUTIVE DIRECTOR OF CRITICAL PATH INSTITUTE’S COALITION AGAINST MAJOR DISEASES TESTIFIES BEFORE CONGRESS ON ALZHEIMER / U.S. House of Representatives / Subcommittee on Health / U.S. Food and Drug Administration / Alzheimer's Association / Alliance for Aging Research / Alzheimer's Foundation of America / Engelberg Center for Health Care Reform / /
Person
Joshua Sharfstein / Raymond Woosley / Marc Cantillon / Mark McClellan / Marcelle Morrison-Bogorad / Eric J. Hall / Alzheimer / Harry Johns / Care Reform / Critical Path Initiative / / /
Position
Executive Director of the Coalition / Development Manager / Director / Division of Neuroscience / Deputy Commissioner / Director / President and CEO / Commissioner / Major / Private / Director of the Coalition Against / international leader / /
FOR IMMEDIATE RELEASE Contact: Lisa Romero Communications & Development Manager[removed]